Future Treatment Options for Multiple Myeloma

  Amrita Krishnan, MD, hematologist-oncologist at the City of Hope Comprehensive Cancer Center, talks about what the future holds for managing people with multiple myeloma. Multiple myeloma is a rare hematologic cancer characterized by the expansion of malignant...

Rozanolixizumab to Treat Immune Thrombocytopenia

  Tadeusz Robak, MD of the Poznań University of Medical Sciences in Poland provides a summary of a phase II clinical trial assessing rozanolixizumab to treat people with primary immune thrombocytopenia. Rozanolixizumab is an anti-Fc receptor antibody and results...

Clinical Trials and Rare Diseases

  Timothy Craig, DO of the Penn State Milton S. Hershey Medical Center talks about the need for clinicians to be educated about the pros and cons of entering a clinical trial. Clinical trials, especially those for rare diseases, are excellent opportunities for...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.